Log in
Enquire now
‌

Syntis Bio

Syntis Bio is a Boston-based biotech (founded 2025 by MIT’s Langer, Traverso & team) developing oral therapies targeting metabolic control in the small intestine.

OverviewStructured DataIssuesContributors
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Syntis Bio

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.